Neighborhood greenness and burden of non-communicable diseases in Sub-Saharan Africa: A multi-country cross-sectional study.

Africa South of the Sahara / epidemiology Cross-Sectional Studies Humans Noncommunicable Diseases / epidemiology Overweight Risk Factors
Environmental epidemiology Greenness Non-communicable diseases Obesity Sub-saharan Africa Vegetation

Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
05 2021
Historique:
received: 29 03 2020
revised: 15 10 2020
accepted: 23 10 2020
pubmed: 2 11 2020
medline: 4 6 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Population growth, demographic transitions and urbanization in sub-Saharan Africa (SSA) will increase non-communicable disease (NCD) burden. We studied the association between neighborhood greenness and NCDs in a multi-country cross-sectional study. Among 1178 participants, in adjusted models, a 0.11 unit NDVI increase was associated with lower BMI (β: -1.01, 95% CI: -1.35, -0.67), and lower odds of overweight/obesity (aOR: 0.73, 95% CI: 0.62, 0.85), diabetes (aOR: 0.77, 95% CI: 0.62, 0.96), and having ≥3 allostatic load components compared to none (aOR: 0.66, 95% CI: 0.52, 0.85). Except for diabetes, these remained statistically significant after Bonferroni correction. We observed no association between NDVI and hypertension or cholesterol. Our findings are consistent with health benefits of neighborhood greenness reported in other countries, suggesting greening strategies could be considered as part of broader public health interventions for NCDs.

Identifiants

DOI: 10.1016/j.envres.2020.110397 PMID: 33130166 PMC: PMC8085185
pubmed: 33130166
pii: S0013-9351(20)31294-9
doi: 10.1016/j.envres.2020.110397
pmc: PMC8085185
mid: NIHMS1644256
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02927249']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110397

Subventions

Organisme : NHGRI NIH HHS
ID : U54 HG006947
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009001
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA184374
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA201542
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL150119
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Environ Health Perspect. 2016 Aug;124(8):1291-8
pubmed: 26863688
Circulation. 2016 Jun 14;133(24):2561-75
pubmed: 27297348
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S6-10
pubmed: 25962950
Lancet Oncol. 2013 Apr;14(4):e189-95
pubmed: 23561751
Int J Epidemiol. 2017 Oct 1;46(5):1421-1432
pubmed: 28582528
Environ Res. 2016 Nov;151:168-173
pubmed: 27494536
Environ Res. 2018 Jan;160:372-384
pubmed: 29059619
Public Health Rev. 2016 Nov 29;37:27
pubmed: 29450068
Ann N Y Acad Sci. 1998 May 1;840:33-44
pubmed: 9629234
Glob Health Action. 2016 May 23;9:31440
pubmed: 27221531
Environ Int. 2017 Nov;108:176-184
pubmed: 28863390
Lancet Planet Health. 2017 Oct;1(7):e289-e297
pubmed: 29851627
Environ Res. 2018 Nov;167:175-183
pubmed: 30029039
J Am Heart Assoc. 2018 Dec 18;7(24):e009117
pubmed: 30561265
Epidemiology. 2017 May;28(3):399-402
pubmed: 28166102
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
Cancer. 2012 Sep 15;118(18):4372-84
pubmed: 22252462
Lancet Planet Health. 2019 Nov;3(11):e469-e477
pubmed: 31777338
Curr Epidemiol Rep. 2015 Jun;2(2):131-142
pubmed: 26185745
Public Health. 2013 Apr;127(4):318-24
pubmed: 23587672
J Phys Act Health. 2016 Sep;13(9):938-45
pubmed: 27172614
Environ Res. 2018 Oct;166:628-637
pubmed: 29982151
J Am Heart Assoc. 2019 Mar 19;8(6):e010258
pubmed: 30835593
Environ Health Perspect. 2019 Feb;127(2):27002
pubmed: 30775931
Lancet. 2014 Jan 4;383(9911):3-4
pubmed: 24388297
Arch Intern Med. 1997 Oct 27;157(19):2259-68
pubmed: 9343003
S Afr Med J. 2016 Sep 23;106(10):996-1001
pubmed: 27725020
Environ Epidemiol. 2020 Apr 09;4(2):e087
pubmed: 32337472
Environ Health Perspect. 2016 Sep;124(9):1344-52
pubmed: 27074702
Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):117-27
pubmed: 18336737
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
Int J Epidemiol. 2011 Aug;40(4):885-901
pubmed: 21527446
Environ Res. 2017 Oct;158:508-521
pubmed: 28709033
Annu Rev Public Health. 2019 Apr 1;40:261-282
pubmed: 30633714
Am J Prev Med. 2016 Jul;51(1):78-89
pubmed: 27061891
Lancet. 2018 May 19;391(10134):2029-2035
pubmed: 29627167
Environ Pollut. 2019 Jul;250:14-22
pubmed: 30981931
Lancet Planet Health. 2017 Jul;1(4):e152-e162
pubmed: 28890948
BMC Public Health. 2016 Oct 28;16(1):1126
pubmed: 27793143
Environ Health Prev Med. 2010 Jan;15(1):18-26
pubmed: 19568835
Sci Adv. 2019 Jul 24;5(7):eaax0903
pubmed: 31355340
Curr Environ Health Rep. 2018 Mar;5(1):77-87
pubmed: 29392643
J Gen Intern Med. 2000 Jun;15(6):395-9
pubmed: 10886474
Glob Health Action. 2015 May 25;8:27422
pubmed: 26015082
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
Int J Hyg Environ Health. 2019 Mar;222(2):283-290
pubmed: 30545606
Diabetes Care. 2014;37(1):197-201
pubmed: 24026544
BMC Public Health. 2015 Dec 05;15:1211
pubmed: 26637309
Environ Health. 2014 Mar 19;13(1):20
pubmed: 24645935
Int J Environ Res Public Health. 2019 Dec 05;16(24):
pubmed: 31817351
Soc Sci Med. 2014 Apr;107:9-17
pubmed: 24602966
Bull World Health Organ. 2019 Feb 1;97(2):142-153
pubmed: 30728620
Int J Environ Res Public Health. 2016 Dec 03;13(12):
pubmed: 27918478

Auteurs

Hari S Iyer (HS)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA. Electronic address: Hari_Iyer@dfci.harvard.edu.

Peter James (P)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA.

Linda Valeri (L)

Department of Biostatistics, Columbia University Mailman School of Public Health, New York, USA.

Francis Bajunirwe (F)

Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda.

Joan Nankya-Mutyoba (J)

Department of Epidemiology & Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.

Marina Njelekela (M)

Department of Physiology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania; Department of Internal Medicine, Muhimbili National Hospital, Dar Es Salaam, Tanzania; Deloitte Consulting Limited, Dar Es Salaam, Tanzania.

Faraja Chiwanga (F)

Department of Internal Medicine, Muhimbili National Hospital, Dar Es Salaam, Tanzania.

Vikash Sewram (V)

African Cancer Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

IkeOluwapo Ajayi (I)

Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Clement Adebamowo (C)

Institute of Human Virology, Abuja, Nigeria; Greenebaum Comprehensive Cancer Center and Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA.

Shona Dalal (S)

Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA.

Todd G Reid (TG)

Media Lab and Connection Science, Massachusetts Institute of Technology, Boston, USA; Department of Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health, Boston, USA.

Timothy R Rebbeck (TR)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA.

Hans-Olov Adami (HO)

Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.

Michelle D Holmes (MD)

Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA; Channing Division of Network Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Neighborhood greenness and burden of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Neighborhood greenness and burden of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Neighborhood greenness and burden of...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies non transmissibles › Neighborhood greenness and burden of...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Apparence corporelle › Surpoids › Neighborhood greenness and burden of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Neighborhood greenness and burden of...